Article
Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Apr 2015
Riedl Christopher C, Luft Nikolaus, Bernhart Clemens, Weber Michael, Bernathova Maria, Tea Muy-Kheng M, Rudas Margaretha, Singer Christian F, Helbich Thomas H
Abstract excerpt
PURPOSE: To evaluate the breast cancer screening efficacy of mammography, ultrasound, and magnetic resonance imaging (MRI) in a high-risk population and in various population subgroups. PATIENTS AND METHODS: In a single-center, prospective, nonrandomized comparison study, BRCA mutation carriers and women with a high familial risk (> 20% lifetime risk) for breast cancer were offered screening with mammography,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.